Cargando…
YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells
Aberrant activation of signal transducer and activator of transcription 3 (STAT3) plays a critical role in the proliferation and survival of multiple myeloma. And inactivation of STAT3 is considered a promising strategy for the treatment of multiple myeloma. Here we show that the sinomenine derivati...
Autores principales: | Wang, Yingying, Wu, Linlin, Cai, Haiyan, Lei, Hu, Ma, Chun-Min, Yang, Li, Xu, Hanzhang, Zhu, Qi, Yao, Zhujun, Wu, Yingli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170385/ https://www.ncbi.nlm.nih.gov/pubmed/30302278 http://dx.doi.org/10.1038/s41420-018-0108-8 |
Ejemplares similares
-
Sinomenine derivative YL064: a novel STAT3 inhibitor with promising anti-myeloma activity
por: Wang, Yingying, et al.
Publicado: (2018) -
YL064 activates proteasomal-dependent degradation of c-Myc and synergistically enhances the anti-tumor activity of ABT-199 in diffuse large B cell lymphoma
por: Shan, Huizhuang, et al.
Publicado: (2020) -
TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma
por: Nakayama, Kazuhide, et al.
Publicado: (2018) -
Directly targeting c-Myc contributes to the anti-multiple myeloma effect of anlotinib
por: Cao, Yang, et al.
Publicado: (2021) -
Piperlongumine induces apoptosis and reduces bortezomib resistance by inhibiting STAT3 in multiple myeloma cells
por: Yao, Yao, et al.
Publicado: (2016)